Abeille Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$11.4M Sell
241,426
-1,171
-0.5% -$94.9K 0.4% 68
2022
Q3
$19.6M Sell
242,597
-68,575
-22% -$6.16M 0.76% 51
2022
Q2
$27.9M Sell
311,172
-9,385
-3% -$951K 0.99% 41
2022
Q1
$35.6M Buy
+320,557
New +$33.9M 1.02% 42

Other funds holding MDT

Abeille Asset Management's MDT Position: Q4 2022 in Review

Abeille Asset Management reduced its Medtronic (MDT) stake by 0.48% in Q4 2022, selling an estimated $94.9K and leaving 241,426 shares worth $11.4M. The position accounts for 0.4% of the portfolio, ranked #68.

Abeille Asset Management first reported a position in MDT in Q1 2022 and has held it in 4 quarters since. The position peaked at $35.6M in Q1 2022. 1,961 funds tracked by Wall St. Rank hold MDT as of Q4 2022.

  • Abeille Asset Management held 241,426 shares of Medtronic worth $11.4M as of Q4 2022.
  • Abeille Asset Management sold 1,171 Medtronic shares in Q4 2022, an estimated $94.9K.
  • Medtronic made up 0.4% of Abeille Asset Management's portfolio in Q4 2022, its #68 holding.
  • Abeille Asset Management first reported a position in Medtronic in Q1 2022 and has held it in 4 quarters since.
  • Abeille Asset Management's Medtronic position peaked at $35.6M in Q1 2022.
  • 1,961 funds tracked by Wall St. Rank held Medtronic as of Q4 2022.

Based on Abeille Asset Management's 13F filing for Q4 2022, filed 20 Jan 2023.